| __timestamp | Jazz Pharmaceuticals plc | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 504755000 |
| Thursday, January 1, 2015 | 449119000 | 838526000 |
| Friday, January 1, 2016 | 502892000 | 1177697000 |
| Sunday, January 1, 2017 | 544156000 | 1320433000 |
| Monday, January 1, 2018 | 683530000 | 1556200000 |
| Tuesday, January 1, 2019 | 736942000 | 1834800000 |
| Wednesday, January 1, 2020 | 854233000 | 1346000000 |
| Friday, January 1, 2021 | 1451683000 | 1824900000 |
| Saturday, January 1, 2022 | 1416967000 | 2115900000 |
| Sunday, January 1, 2023 | 1343105000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding the financial strategies of industry leaders is crucial. Over the past decade, Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Regeneron has consistently outpaced Jazz, with its SG&A expenses growing by approximately 420%, peaking in 2023. Jazz, while showing a steady increase, saw its expenses rise by about 230% over the same period. This divergence highlights Regeneron's aggressive investment in administrative and sales capabilities, potentially fueling its market expansion. Meanwhile, Jazz's more conservative growth suggests a focus on efficiency and cost management. These trends offer a window into the strategic priorities of these pharmaceutical powerhouses, reflecting broader industry dynamics and competitive positioning.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Jazz Pharmaceuticals plc
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.